JPH11504023A - （Ｓ）−アデノシル−Ｌ−メチオニン（ＳＡＭｅ）の新規使用 - Google Patents

（Ｓ）−アデノシル−Ｌ−メチオニン（ＳＡＭｅ）の新規使用

Info

Publication number
JPH11504023A
JPH11504023A JP8532131A JP53213196A JPH11504023A JP H11504023 A JPH11504023 A JP H11504023A JP 8532131 A JP8532131 A JP 8532131A JP 53213196 A JP53213196 A JP 53213196A JP H11504023 A JPH11504023 A JP H11504023A
Authority
JP
Japan
Prior art keywords
same
focal
adenosyl
methionine
ischemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8532131A
Other languages
English (en)
Japanese (ja)
Inventor
ネーメト ゲオルク
ディ パドヴァ カルロ
ソボー ラースロー
グロス ゲルハルト
Original Assignee
クノル アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クノル アクチエンゲゼルシャフト filed Critical クノル アクチエンゲゼルシャフト
Publication of JPH11504023A publication Critical patent/JPH11504023A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP8532131A 1995-04-26 1996-04-13 （Ｓ）−アデノシル−Ｌ−メチオニン（ＳＡＭｅ）の新規使用 Pending JPH11504023A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19515275.1 1995-04-26
DE19515275A DE19515275A1 (de) 1995-04-26 1995-04-26 Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
PCT/EP1996/001570 WO1996033727A1 (de) 1995-04-26 1996-04-13 NEUE VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe)

Publications (1)

Publication Number Publication Date
JPH11504023A true JPH11504023A (ja) 1999-04-06

Family

ID=7760373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8532131A Pending JPH11504023A (ja) 1995-04-26 1996-04-13 （Ｓ）−アデノシル−Ｌ−メチオニン（ＳＡＭｅ）の新規使用

Country Status (15)

Country Link
EP (1) EP0822820A1 (no)
JP (1) JPH11504023A (no)
KR (1) KR19990008061A (no)
CN (1) CN1182367A (no)
AR (1) AR001687A1 (no)
AU (1) AU5646396A (no)
CA (1) CA2216854A1 (no)
CZ (1) CZ330597A3 (no)
DE (1) DE19515275A1 (no)
HR (1) HRP960196A2 (no)
IL (1) IL117844A0 (no)
MX (1) MX9707735A (no)
NO (1) NO974941L (no)
WO (1) WO1996033727A1 (no)
ZA (1) ZA963296B (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine
JPS59139319A (ja) * 1983-01-31 1984-08-10 Fuji Kagaku Kogyo Kk 脳障害による身体機能障害治療剤
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体
DE4425280C2 (de) * 1994-07-16 1997-05-07 Knoll Ag Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden

Also Published As

Publication number Publication date
NO974941D0 (no) 1997-10-24
AR001687A1 (es) 1997-11-26
ZA963296B (en) 1997-10-27
NO974941L (no) 1997-10-24
AU5646396A (en) 1996-11-18
EP0822820A1 (de) 1998-02-11
KR19990008061A (ko) 1999-01-25
HRP960196A2 (en) 1998-02-28
CZ330597A3 (cs) 1998-02-18
CA2216854A1 (en) 1996-10-13
WO1996033727A1 (de) 1996-10-31
MX9707735A (es) 1997-12-31
CN1182367A (zh) 1998-05-20
DE19515275A1 (de) 1996-10-31
IL117844A0 (en) 1996-08-04

Similar Documents

Publication Publication Date Title
US20080020988A1 (en) Brain cell- or nerve cell-protecting agents comprising medicinal ginseng
Bentzer et al. Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume
US9402818B2 (en) Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases
JPH11505244A (ja) 躁病および双極性障害の治療法
PT792160E (pt) Factor neurotrofico derivado das celulas gliais utilizado como agente neuroprotector
US6090775A (en) Treatment of neurological conditions by an interleukin-1 inhibiting compound
CN113546082B (zh) 特拉匹韦在制备治疗缺血/再灌注损伤的药物及细胞保护药物中的应用
KR100696417B1 (ko) 진세노사이드 Ｒｂ₁을 함유하는 뇌혈관 재생ㆍ재구축 촉진제 및 신경조직 이차변성 억제제
US8097640B2 (en) Prophylactic or therapeutic agent for diabetic maculopathy
JP2017524727A (ja) 糖尿病の慢性合併症において使用するためのｓｏｃｓ１由来ペプチド
JPH11504023A (ja) （Ｓ）−アデノシル−Ｌ−メチオニン（ＳＡＭｅ）の新規使用
KR20240024083A (ko) 신경병증을 조절하는 방법
CN113975276B (zh) 考比替尼在制备治疗缺血/再灌注损伤药物及细胞保护药物中的应用
Mubarak et al. Effect of caffeine on serum tumour necrosis factor alpha and lactate dehydrogenase in Wistar rats exposed to cerebral ischaemia-reperfusion injury
CN115212194B (zh) 纳多洛尔在制备治疗缺血/再灌注损伤药物及细胞保护药物中的应用
KR102089376B1 (ko) 디아민 유도체를 포함하는 뇌졸중, 신경 세포 손상, 파킨슨병 또는 루게릭병의 예방 또는 치료용 조성물
EP4338798A1 (en) Pharmaceutical preparation containing genistein for use in the prevention or treatment of glaucoma and/or ocular hypertension
DE60019166T2 (de) Verwendung von adatanserin zur behandlung von akuten neurodegenerativen erkrankungen
US20050130978A1 (en) Novel crystal of quinoxalinedione derivative anhydride
CN114617865A (zh) 乙酰左旋肉碱在制备用于预防或治疗静脉流出障碍性疾病的药物中的应用
US20080207631A1 (en) Methods for the treatment and prevention of neurodegenerative conditions
DE3402058A1 (de) Medikament gegen cerebrale apoplexie
JPS59134722A (ja) 出血性梗塞予防・治療剤
AU4752099A (en) Treatment of neurological conditions by an interleukin-1 inhibiting compound